Currently, there are 269.95M common shares owned by the public and among those 269.36M shares have been available to trade.
The company’s stock has a 5-day price change of -2.92% and -7.04% over the past three months. OHI shares are trading 24.56% year to date (YTD), with the 12-month market performance up to 24.40% higher. It has a 12-month low price of $27.53 and touched a high of $44.42 over the same period. OHI has an average intraday trading volume of 1.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.45%, -4.93%, and 5.86% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Omega Healthcare Investors, Inc (NYSE: OHI) shares accounts for 73.35% of the company’s 269.95M shares outstanding.
It has a market capitalization of $10.31B and a beta (3y monthly) value of 0.97. The stock’s trailing 12-month PE ratio is 28.28, while the earnings-per-share (ttm) stands at $1.35. The company has a PEG of 4.71 and the debt-to-equity ratio at 1.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.34% over the week and 1.83% over the month.
Earnings per share for the fiscal year are expected to increase by 50.06%, and 7.97% over the next financial year. EPS should grow at an annualized rate of 6.00% over the next five years, compared to -6.35% over the past 5-year period.
Looking at the support for the OHI, a number of firms have released research notes about the stock. BMO Capital Markets stated their Outperform rating for the stock in a research note on December 09, 2024, with the firm’s price target at $45. Exane BNP Paribas coverage for the Omega Healthcare Investors, Inc (OHI) stock in a research note released on October 31, 2024 offered a Outperform rating with a price target of $49. Berenberg was of a view on October 18, 2024 that the stock is Buy, while Mizuho gave the stock Neutral rating on July 25, 2024, issuing a price target of $34- $35. Citigroup on their part issued Buy rating on March 22, 2024.
